Tirzepatide, currently marketed by Eli Lilly (NYSE:LLY) as Mounjaro and Zepbound for diabetes and weight loss, respectively, ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

The Times of India hosted Medithon-3, a conference dedicated to raising diabetes awareness and promoting early detection.

Doctors say they have not seen anything like this since the emergence of statins to lower cholesterol. But do we know enough ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

Police in Dearborn increase patrols after thieves target pharmacies for the weight loss drug Ozempic, with one suspect ...

Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...